Enovis [ENOV] vs Establishment Labs [ESTA] Detailed Stock Comparison

Enovis Corporation

NYSE
Loading...

Establishment Labs Holdings Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Enovis Corporation wins in 14 metrics, Establishment Labs Holdings Inc. wins in 5 metrics, with 0 ties. Enovis Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Enovis Corporation Establishment Labs Holdings Inc. Better
P/E Ratio (TTM) -1.10 -37.89 Enovis Corporation
Price-to-Book Ratio 0.91 79.68 Enovis Corporation
Debt-to-Equity Ratio 92.47 1,123.15 Enovis Corporation
PEG Ratio 0.04 0.41 Enovis Corporation
EV/EBITDA 7.33 -70.21 Enovis Corporation
Profit Margin (TTM) -52.69% -24.19% Establishment Labs Holdings Inc.
Operating Margin (TTM) 6.09% -6.08% Enovis Corporation
EBITDA Margin (TTM) 6.09% N/A N/A
Return on Equity -58.27% -133.25% Enovis Corporation
Return on Assets (TTM) 1.09% -6.93% Enovis Corporation
Free Cash Flow (TTM) $19.92M $-57.61M Enovis Corporation
1-Year Return -31.66% 119.39% Establishment Labs Holdings Inc.
Price-to-Sales Ratio (TTM) 0.61 8.92 Enovis Corporation
Enterprise Value $2.71B $2.07B Enovis Corporation
EV/Revenue Ratio 1.20 9.79 Enovis Corporation
Gross Profit Margin (TTM) 60.69% 70.46% Establishment Labs Holdings Inc.
Revenue per Share (TTM) $39 $7 Enovis Corporation
Earnings per Share (Diluted) $-20.72 $-1.72 Establishment Labs Holdings Inc.
Beta (Stock Volatility) 1.59 1.08 Establishment Labs Holdings Inc.
Short % of Float 16.89% 22.26% Enovis Corporation

Enovis Corporation vs Establishment Labs Holdings Inc. Stock Performance Analysis

Loading Price Chart...

ENOV
ESTA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Enovis Corporation-3.76%-11.40%-13.63%-9.61%-20.95%-20.86%
Establishment Labs Holdings Inc.2.52%12.52%28.06%32.66%16.91%22.33%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Enovis Corporation-31.66%-63.77%-70.90%-55.34%-45.40%-38.21%
Establishment Labs Holdings Inc.119.39%25.90%5.07%211.25%211.25%211.25%

Performance & Financial Health Analysis: Enovis Corporation vs Establishment Labs Holdings Inc.

MetricENOVESTA
Market Information
Market Cap i$1.31B$1.91B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i793,145451,437
90 Day Avg. Volume i806,505478,309
Last Close$20.98$84.21
52 Week Range$20.55 - $36.82$33.35 - $86.00
% from 52W High-43.02%-2.08%
All-Time High$129.72 (Jun 09, 2014)$93.80 (Apr 18, 2022)
% from All-Time High-83.83%-10.22%
Growth Metrics
Quarterly Revenue Growth0.03%0.45%
Quarterly Earnings Growth0.03%0.45%
Financial Health
Profit Margin (TTM) i-0.53%-0.24%
Operating Margin (TTM) i0.06%-0.06%
Return on Equity (TTM) i-0.58%-1.33%
Debt to Equity (MRQ) i92.471,123.15
Cash & Liquidity
Book Value per Share (MRQ)$26.05$0.80
Cash per Share (MRQ)$0.64$2.58
Operating Cash Flow (TTM) i$217.29M$-50,890,000
Levered Free Cash Flow (TTM) i$104.43M$-41,574,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Enovis Corporation vs Establishment Labs Holdings Inc.

MetricENOV (Apr 23, 2026)ESTA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-1.10-37.89
Forward P/E i5.94316.35
PEG Ratio i0.040.41
Price to Sales (TTM) i0.618.92
Price to Book (MRQ) i0.9179.68
Market Capitalization
Market Capitalization i$1.31B$1.91B
Enterprise Value i$2.71B$2.07B
Enterprise Value Metrics
Enterprise to Revenue i1.209.79
Enterprise to EBITDA i7.33-70.21
Risk & Other Metrics
Beta i1.591.08
Book Value per Share (MRQ) i$26.05$0.80

Financial Statements Comparison: Enovis Corporation vs Establishment Labs Holdings Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricENOV (2025)ESTA (2025)
Revenue/Sales i2.25B211.08M
Cost of Goods Sold i902.79M64.77M
COGS % of Revenue i40.2%30.7%
Gross Profit i1.35B146.31M
Gross Margin i59.8%69.3%
Research & Development i120.33M20.25M
Operating Income (EBIT) i-18.87M-39.01M
Operating Margin i-0.8%-18.5%
EBITDA i275.14M-22.29M
EBITDA Margin i12.2%-10.6%
Pre-Tax Income i-1.16B-58.02M
Pre-Tax Income % of Revenue i-51.6%-27.5%
Income Tax i22.29M-6.96M
Income Tax % of Revenue i1.0%-3.3%
Net Income (Profit) i-1.18B-51.06M
Profit Margin i-52.7%-24.2%

Balance Sheet & Liquidity Metrics

MetricENOV (2025)ESTA (2025)
Cash & Equivalents i36.39M75.57M
Total Current Assets i1.21B249.94M
Total Current Assets % of Revenue i53.7%118.4%
Total Current Liabilities i598.47M82.14M
Total Current Liabilities % of Revenue i26.6%38.9%
Long-Term Debt i1.32B250.34M
Long-Term Debt % of Revenue i58.7%118.6%
Total Shareholders Equity i1.49B23.55M
Retained Earnings i-1.47B-495.76M
Retained Earnings % of Revenue i-65.3%-234.9%
Property, Plant & Equipment i72.26M4.34M

Cash Flow Statement Comparison

MetricENOV (2025)ESTA (2025)
Operating Cash Flow i-835.70M-50.78M
Operating Cash Flow % of Revenue i-37.2%-24.1%
Capital Expenditures i-197.38M-6.05M
Free Cash Flow i19.92M-57.61M
FCF Margin i0.9%-27.3%
Debt Repayment i-580.93M-1.02M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricENOVESTA
Shares Short i8.15M5.22M
Short Ratio i8.669.90
Short % of Float i16.89%22.26%
Shares Outstanding i57.19M29.30M
Float Shares i56.33M19.22M
% Held by Insiders i1.48%10.16%
% Held by Institutions i117.25%102.08%
% Held by Public i-18.73%-12.24%

Dividend Analysis & Yield Comparison: Enovis Corporation vs Establishment Labs Holdings Inc.

MetricENOVESTA
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A